[SIZE="2"]USA Specific: CMS HCPCS G-Codes
11 messages
Deepak Mohan <[email protected]> Thu, Nov 13, 2008 at 12:14 PM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
Does anyone have any details on HCPCS G-codes? Apparently we need to
use it for prostate billing starting Jan 2009 as opposed to the 88305
Cpt code.
--
Deepak Mohan, MD | Laboratory Medical Director | San Joaquin General Hospital
500 West Hospital Road | French Camp, CA 95231 | (209) 468-6069 |
(209) 468-6386 | [email protected] | http://www.sjgeneralhospital.com/
_______________________________________________
PATHO-L mailing list
[email protected]
http://www.mailman.srv.ualberta.ca/mailman/listinfo/patho-l
Adel Assaad <[email protected]> Thu, Nov 13, 2008 at 2:39 PM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
First I hear of it but a quick look at CMS website
http://www.cms.hhs.gov/HCPCSReleaseCodeSets/ANHCPCS/itemdetail.asp?filterType=none&filterByDID=-99&sortByDID=1&sortOrder=descending&itemID=CMS1216704&intNumPerPage=10
yields the following codes:
G0416
00100
3
SURGICAL PATHOLOGY, GROSS AND MICROSCOPIC EXAMINATION FOR PROSTATE NEEDLE
Sat biopsy prostate 1-20 spc
13
G0416
00200
4
SATURATION BIOPSY SAMPLING, 1-20 SPECIMENS
G0417
00100
3
SURGICAL PATHOLOGY, GROSS AND MICROSCOPIC EXAMINATION FOR PROSTATE NEEDLE
Sat biopsy prostate 21-40
13
G0417
00200
4
SATURATION BIOPSY SAMPLING, 21-40 SPECIMENS
G0418
00100
3
SURGICAL PATHOLOGY, GROSS AND MICROSCOPIC EXAMINATION FOR PROSTATE NEEDLE
Sat biopsy prostate 41-60
13
G0418
00200
4
SATURATION BIOPSY SAMPLING, 41-60 SPECIMENS
G0419
00100
3
SURGICAL PATHOLOGY, GROSS AND MICROSCOPIC EXAMINATION FOR PROSTATE NEEDLE
Sat biopsy prostate: >60
13
G0419
00200
4
SATURATION BIOPSY SAMPLING, GREATER THAN 60 SPECIMENS
Adel Assaad Seattle, WA
_________________________________________________________________
Stay up to date on your PC, the Web, and your mobile phone with Windows Live
http://clk.atdmt.com/MRT/go/119462413/direct/01/
[Quoted text hidden]
Deepak Mohan <[email protected]> Thu, Nov 13, 2008 at 2:58 PM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
What is saturation biopsy sampling? Is it the same as Prostate needle
core biopsy?
They probably mean total number of cores when they say "Number of
specimens". We usually refer to specimens as a specific anatomic site
(in separate cointainer) and bill one 88305 for each container. So we
just bill one code based on number of cores (1-20, 21-40, 41-60, >60)?
Is everyone planning on using these codes? What if we continue to use
the cpt code of 88305?
Dr. Mohan
[Quoted text hidden]
--
Deepak Mohan, MD | Laboratory Medical Director | San Joaquin General Hospital
500 West Hospital Road | French Camp, CA 95231 | (209) 468-6069 |
(209) 468-6386 | [email protected] | http://www.sjgeneralhospital.com/
_______________________________________________
[Quoted text hidden]
Lester Raff MD <[email protected]> Thu, Nov 13, 2008 at 3:02 PM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
Saturation sampling generally refers to the procedure in which far more
biopsies are taken than in the general urology office practice, usually
as a follow up to a previous abnormality, or when several office
biopsies have been negative but PSA continues to rise. The number of
biopsies can be over 100, although we usually get them in 8 vials from
the Prostate Cancer Center in our area, and thus bill 88305x8
I am HOPING that these new codes won't be applied to the sextant or 12
part biopsies most urologists do in their offices.
Lester J. Raff, MD
Medical Director
UroPartners Laboratory
2225 Enterprise Dr. Suite 2511
Westchester, Il 60154
Tel 708.486.0076
Fax 708.486.0080
[Quoted text hidden]
[email protected] <[email protected]> Thu, Nov 13, 2008 at 3:10 PM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
-------------- Original message ----------------------
From: "Lester Raff MD" <[email protected]>
> I am HOPING that these new codes won't be applied to the sextant or 12
> part biopsies most urologists do in their offices.
Looks to me like someone has managed to kill the goose that laid the golden eggs.
Bill
--
William D. Kasimer
[email protected]
[email protected]
[Quoted text hidden]
Warren White <[email protected]> Thu, Nov 13, 2008 at 3:32 PM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
Whatever is the absolute worst case scenario for the pathologist; that
is what this means and what will happen. Have a nice day........
WWhite
[Quoted text hidden]
Adel Assaad <[email protected]> Thu, Nov 13, 2008 at 8:23 PM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
The G codes are to be used for saturation biopsies only when a specific clinical CPT code is applied. see statline issue below, article about final fee schedule.
The cash cow lives another year...
Adel Assaad Seattle, WA
From: [email protected]: [email protected]: STATLINE--November 13, 2008 (Volume 24, Number 23)Date: Thu, 13 Nov 2008 12:48:25 -0600
>From the College of American PathologistsNovember 13, 2008 volume 24, number 23
View and print the complete STATLINE(http://www.cap.org/apps/docs/hints/index1.html)
Rep. Ehlers Takes Lab TourRep. Vern Ehlers (R-MI) views a digital cytology slide with Robert Knapp, MD, FCAP.Go to full story
CAP-led Cytology Proficiency Improvement Coalition Discusses CPT Regulation with OMBA delegation of pathologists and College staff representing the Cytology Proficiency Testing Improvement Coalition met with the Office of Management and Budget (OMB) and US Department of Health and Human Services Nov. 6 to recommend alternatives to proposed Cytology PT regulations submitted last month by the Centers for Medicare and Medicaid Services to OMB for review and approval prior to publication.Go to full story
CMS Releases 2009 Physician Fee Schedule Final RuleThe 2009 Physician Fee Schedule Final Rule was released by the Centers for Medicare and Medicaid Services, including an extension for the technical component grandfather and the Physician Quality Reporting Initiative, updates to the clinical lab fee schedule and the conversion factor, and a requirement for the use of new G codes for specific prostate biopsy saturation sampling.Go to full story
New CPT II Code for Breast and Colorectal Cancer ApprovedA new CPT II code will be available in 2009 for reporting on the PQRI breast and colorectal cancer reporting measures in addition to three codes currently available (3260F, 3260F-1P, 3260F-8P).Go to full story
Election Day 2008 Charts New Path in Direction ofHealthcare Policy ReformElection Day 2008 heralded in sweeping changes to both the Executive and Legislative branches of government, and with them the direction of healthcare policy reform.Go to full story
Senator Baucus Unveils Universal Healthcare PlanSenate Finance Committee Chairman Max Baucus (D-MT) unveiled a universal-coverage healthcare call to action this week, in a move that pushes medical policy reform amongst the top of the 111th Congress' agenda with an emphasis on improving value by reforming health care delivery.Go to full story
AMA House of Delegates Discusses Physician Payment andthe Medical HomeAlternative physician payments strategies, the principles of the patient-centered medical home, comparative effectiveness research and other issues of healthcare reform were key topics at the American Medical Association House of Delegates meeting in Orlando, Fla. Nov. 8-11.Go to full story
Illinois Court Upholds Pathologists Right to Bill forProfessional ComponentThe right of pathologists to bill for the professional component of clinical pathology services was upheld by an Illinois circuit court ruling Nov. 3, citing an Amicus Curiae brief by the College, in a case where a clinic refuses to pay a laboratory for the services.Go to full story
Advocacy BriefsMichael Merwin, MD, FCAP, hosted Rep. Mike Thompson (R-TX) during a lab tour at Queen of the Valley Medical Center in Napa, CA, Nov. 7.Go to full story
(For Statline reprint permission, please contact Justin Herman.)
Visit the STATLINE archive
STATLINE is published biweekly.Justin Herman, editor, 800-392-9994 ext. 7127.
Information About This Service
The CAP member mailing list is closed and confidential. Its purpose is to distribute important news and information to CAP members. Individual members are not able to post messages to the list.
Visit the CAP Web site for additional news and information. If you have comments or questions regarding this mailing list, contact Justin Herman at 800-392-9994 ext. 7127, or [email protected].
To remove yourself from this list, go to http://leda.cap.org/UM/U.asp?B1.98.14089.161192 and you will be removed immediately. Thank you.
© 2008 College of American Pathologists325 Waukegan RoadNorthfield, IL 60093
_________________________________________________________________
Get 5 GB of storage with Windows Live Hotmail.
http://windowslive.com/Explore/Hotmail?ocid=TXT_TAGLM_WL_hotmail_acq_5gb_112008
[Quoted text hidden]
[email protected] <[email protected]> Fri, Nov 14, 2008 at 7:43 AM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
This has always been a game of being "one-step-ahead."
When Urologists realized that Medicare would pay for each separate 88305,
they decided start their own labs, and stop the "naive" practice of dumping
multiple biopsies into one container. Soon, the total amount that medicare
was paying out for this became big enough for people to take notice and
realize that one did not need 18 to 24 diagnoses on each patient with a
elevated PSA. (Do the math for the millions of patients with elevated PSAs
who undergo prostate biopsies).
There were 28 million males (approx. 2000 census), between 50 and 75.
Between 2001 and 2004, approximately 58% of American males above 50 had had
a PSA done in the previous year (CDCP data 2002-2005), for approximately 16
million. If even only 10% of these, or 1.8 million had elevated PSA leading
to biopsies, annually (This number is not unreasonable, as it is about 7
times the estimated number of new cases of prostate cancer for 2007),
raising the average number of 88305s from 2/ per case (3 left cores, and 3
right cores) to an average of just six, would raise the number of units
from 3.2 million to 10 million. Even at just 100 dollars dollars a unit ,
that comes to a Billion dollars a year.(i'm not even including 88342s that
I often see on multiple biopsies with wall to wall cancer from some of the
Pod labs) The cost is probably closer to 3-4 billion dollars per year, just
for screening!.
This is not the first time that physicians have tried to game the system,
and we can rest assured that whatever medicare comes up with - someone,
somewhere is going to find a creative "solution" for it, that will be
technically legal and its going to be back to the drawing board again for
Medicare.
Mahesh.
PS: Why is it that excellent academic oncological urologists seem to be
satisfied with multiple cores in three to four - occasionally six -
containers, but private practice urologists with their own Pod labs - who
will never enter an operating room because of the unfavorable CPT codes -
find the need for 18-24 separate diagnoses on every patient with an
elevated PSA?
[Quoted text hidden]
Mahesh M. Mansukhani, MD
Associate Professor of Clinical Pathology
Director, CUMC Molecular Pathology Laboratory
Columbia University Medical Center, New York NY 10032
VC14-237; 212-305-2646
[Quoted text hidden]
[email protected] <[email protected]> Fri, Nov 14, 2008 at 7:49 AM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
>
> The G codes are to be used for saturation biopsies only when a specific
> clinical CPT code is applied. see statline issue below, article about
> final fee schedule. The cash cow lives another year...
> Adel Assaad Seattle, WA
I guess this means we will have to know which CPT code the urologist used
to obtain the biopsy?
Mahesh.
Mahesh M. Mansukhani, MD
Associate Professor of Clinical Pathology
Director, CUMC Molecular Pathology Laboratory
Columbia University Medical Center, New York NY 10032
VC14-237; 212-305-2646
_______________________________________________
[Quoted text hidden]
Ed Uthman <[email protected]> Fri, Nov 14, 2008 at 11:27 AM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
At 02:32 PM 11/13/2008, Warren White wrote:
>Whatever is the absolute worst case scenario for the pathologist; that
>is what this means and what will happen. Have a nice day........
Hasta la vista, pod labs! Maybe you can move on to homeopathy clinics
or something.
Ed
-----
Ed Uthman, MD ([email protected])
Pathologist, Houston/Richmond, Texas, USA
http://web2.airmail.net/uthman
http://www.flickr.com/photos/euthman
[Quoted text hidden]
Warren White <[email protected]> Fri, Nov 14, 2008 at 12:20 PM
Reply-To: Pathology Discussion Group <[email protected]>
To: Pathology Discussion Group <[email protected]>
To avoid any misconceptions: Our lab (myself included) has not and does
not participate in any pod-lab/condo-lab scenario, any account bill/MD
office bill scam, or any clinician owned lab at any level.
Seems to me that the recent CMS anti-mark up ruling (and not the
mysterious "G" code), as I read it, will effectively kill the pod-lab
scenario (probably anyway). It does absolutely nothing to kill the
in-office clinician owned AP lab scenario as there are too many
loopholes for it to be effective in that regard. Again, this latter
scenario is not a pod-lab. It is a different beast altogether.
In my state (NC) it would be completely legal for an endoscopy center or
urology group (without the help of a pathologist) to have their own AP
lab in their office, bill all payors - including Medicare - for the full
technical component and get paid using the same pathology codes that we
use. They can then take the slides that they made (with no supervising
pathologist), mail them to a commercial lab, purchase the professional
reading for $10, mark that purchased professional component up to
whatever and, again using the same path codes we do, bill it and get
paid. The only thing they cannot do is mark-up the purchased
professional component for Medicare cases.
"G" codes? My office just called CMS and the person on the phone said:
"Never heard of them". The lowest level of "G" code for prostate
biopsies BTW pays $550, the next level over $1000. So - I would think
those numbers would still be attractive to clinician-owned in office AP
labs as those numbers are fairly close to the current reimbursement.
Hence my prior negative comment. Pathology as an independent practice of
medicine is not gaining any ground as far as I can tell. Have a nice
day........
WWhite
[/SIZE]